Did You Know: 1962-1963: In the United States, Howard Lotsof administers ibogaine to 1-9 individuals at dosages of 6 to 19 mg/kg, including 7 with opioid dependence who note an apparent effect on acute withdrawal symptomatology. http://www.mindsalive.org/history-of-ibogaine/
1939-1970: Ibogaine is sold in France as Lambarene, a “neuromuscular stimulant,” in 8 mg tablets, recommended for indications that include fatigue, depression, and recovery from infectious disease. Visit Our Website For More Information http://www.mindsalive.org/history-of-ibogaine/
1901-1905: The first pharmacodynamic studies of ibogaine are performed. During this period ibogaine is recommended as a treatment for “asthenia” at a dosage range of 10 to 30 mg per day. #IbogaineDurban #ibogaineSouthAfrica http://www.mindsalive.org/history-of-ibogaine/
The 2016 Global Ibogaine Conference will gather ibogaine experts from around the world to discuss ibogaine therapy, sustainability, and traditional uses from March 14-16, 2016 in Tepoztlan, Mexico. MAPS-sponsored researcher Tom Kingsley Brown, Ph.D., will present results from MAPS' ibogaine treatment for addiction. ibogaineconference.org
For the last 40 years it has increasingly been used as a highly promising therapy for detoxification from drugs that cause dependence as it has a unique property whereby it significantly removes painful physical withdrawal symptoms with only a single dose. It also reduces cravings and acts as a natural antidepressant for prolonged periods of time.